Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Profiling of Histone Post-Translational Modifications in Mouse Brain with High-Resolution Top-Down Mass Spectrometry.

Zhou M, Paša-Tolić L, Stenoien DL.

J Proteome Res. 2017 Feb 3;16(2):599-608. doi: 10.1021/acs.jproteome.6b00694. Epub 2016 Dec 21.

PMID:
28001079
2.

Profiling Changes in Histone Post-translational Modifications by Top-Down Mass Spectrometry.

Zhou M, Wu S, Stenoien DL, Zhang Z, Connolly L, Freitag M, Paša-Tolić L.

Methods Mol Biol. 2017;1507:153-168.

PMID:
27832539
3.

Identification of Differential Gene Expression Patterns after Acute Exposure to High and Low Doses of Low-LET Ionizing Radiation in a Reconstituted Human Skin Tissue.

Tilton SC, Markillie LM, Hays S, Taylor RC, Stenoien DL.

Radiat Res. 2016 Nov;186(5):531-538. Epub 2016 Nov 1.

PMID:
27802111
4.

Data integration reveals key homeostatic mechanisms following low dose radiation exposure.

Tilton SC, Matzke MM, Sowa MB, Stenoien DL, Weber TJ, Morgan WF, Waters KM.

Toxicol Appl Pharmacol. 2015 May 15;285(1):1-11. doi: 10.1016/j.taap.2015.01.019. Epub 2015 Feb 2.

PMID:
25655199
5.

Quantitative Proteomic Profiling of Low-Dose Ionizing Radiation Effects in a Human Skin Model.

Hengel SM, Aldrich JT, Waters KM, Pasa-Tolic L, Stenoien DL.

Proteomes. 2014 Jul 29;2(3):382-398. doi: 10.3390/proteomes2030382.

6.

High-throughput proteomics.

Zhang Z, Wu S, Stenoien DL, Paša-Tolić L.

Annu Rev Anal Chem (Palo Alto Calif). 2014;7:427-54. doi: 10.1146/annurev-anchem-071213-020216. Review.

PMID:
25014346
7.

Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate.

Waters KM, Stenoien DL, Sowa MB, von Neubeck C, Chrisler WB, Tan R, Sontag RL, Weber TJ.

Radiat Res. 2013 Jan;179(1):53-61. doi: 10.1667/RR3056.1. Epub 2012 Nov 13.

PMID:
23148505
8.

Enhanced top-down characterization of histone post-translational modifications.

Tian Z, Tolić N, Zhao R, Moore RJ, Hengel SM, Robinson EW, Stenoien DL, Wu S, Smith RD, Paša-Tolić L.

Genome Biol. 2012 Oct 3;13(10):R86. doi: 10.1186/gb-2012-13-10-r86.

9.

Quantitative phosphoproteomics identifies filaggrin and other targets of ionizing radiation in a human skin model.

Yang F, Waters KM, Webb-Robertson BJ, Sowa MB, von Neubeck C, Aldrich JT, Markillie LM, Wirgau RM, Gritsenko MA, Zhao R, Camp DG 2nd, Smith RD, Stenoien DL.

Exp Dermatol. 2012 May;21(5):352-7. doi: 10.1111/j.1600-0625.2012.01470.x.

10.

Phosphoproteomics profiling of human skin fibroblast cells reveals pathways and proteins affected by low doses of ionizing radiation.

Yang F, Waters KM, Miller JH, Gritsenko MA, Zhao R, Du X, Livesay EA, Purvine SO, Monroe ME, Wang Y, Camp DG 2nd, Smith RD, Stenoien DL.

PLoS One. 2010 Nov 30;5(11):e14152. doi: 10.1371/journal.pone.0014152.

11.

Two-dimensional liquid chromatography system for online top-down mass spectrometry.

Tian Z, Zhao R, Tolić N, Moore RJ, Stenoien DL, Robinson EW, Smith RD, Paša-Tolić L.

Proteomics. 2010 Oct;10(20):3610-20. doi: 10.1002/pmic.201000367.

12.

Combined pulsed-Q dissociation and electron transfer dissociation for identification and quantification of iTRAQ-labeled phosphopeptides.

Yang F, Wu S, Stenoien DL, Zhao R, Monroe ME, Gritsenko MA, Purvine SO, Polpitiya AD, Tolić N, Zhang Q, Norbeck AD, Orton DJ, Moore RJ, Tang K, Anderson GA, Pasa-Tolić L, Camp DG 2nd, Smith RD.

Anal Chem. 2009 May 15;81(10):4137-43. doi: 10.1021/ac802605m.

13.

Linear discriminant analysis-based estimation of the false discovery rate for phosphopeptide identifications.

Du X, Yang F, Manes NP, Stenoien DL, Monroe ME, Adkins JN, States DJ, Purvine SO, Camp DG 2nd, Smith RD.

J Proteome Res. 2008 Jun;7(6):2195-203. doi: 10.1021/pr070510t. Epub 2008 Apr 19.

14.

Identification of a novel mitotic phosphorylation motif associated with protein localization to the mitotic apparatus.

Yang F, Camp DG 2nd, Gritsenko MA, Luo Q, Kelly RT, Clauss TR, Brinkley WR, Smith RD, Stenoien DL.

J Cell Sci. 2007 Nov 15;120(Pt 22):4060-70. Epub 2007 Oct 30.

15.

Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation.

Stenoien DL, Knyushko TV, Londono MP, Opresko LK, Mayer MU, Brady ST, Squier TC, Bigelow DJ.

Am J Physiol Cell Physiol. 2007 Jun;292(6):C2084-94. Epub 2007 Feb 7.

16.

Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation.

Yang F, Stenoien DL, Strittmatter EF, Wang J, Ding L, Lipton MS, Monroe ME, Nicora CD, Gristenko MA, Tang K, Fang R, Adkins JN, Camp DG 2nd, Chen DJ, Smith RD.

J Proteome Res. 2006 May;5(5):1252-60.

PMID:
16674116
17.

Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.

Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, Weigel NL, Moran T, Mikic I, Price JH, Mancini MA.

J Cell Biochem. 2006 Jul 1;98(4):770-88.

PMID:
16440331
18.

Regulation of inducible nitric oxide synthase by aggresome formation.

Kolodziejska KE, Burns AR, Moore RH, Stenoien DL, Eissa NT.

Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4854-9. Epub 2005 Mar 21.

19.

Dynamic motion of helix A in the amino-terminal domain of calmodulin is stabilized upon calcium activation.

Chen B, Mayer MU, Markillie LM, Stenoien DL, Squier TC.

Biochemistry. 2005 Jan 25;44(3):905-14.

PMID:
15654746
20.

Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells.

Sasai K, Katayama H, Stenoien DL, Fujii S, Honda R, Kimura M, Okano Y, Tatsuka M, Suzuki F, Nigg EA, Earnshaw WC, Brinkley WR, Sen S.

Cell Motil Cytoskeleton. 2004 Dec;59(4):249-63.

PMID:
15499654
21.

Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response.

Sharp ZD, Stenoien DL, Mancini MG, Ouspenski II, Mancini MA.

J Cell Biochem. 2004 Jul 1;92(4):664-78.

PMID:
15211565
23.

The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation.

Contreras A, Hale TK, Stenoien DL, Rosen JM, Mancini MA, Herrera RE.

Mol Cell Biol. 2003 Dec;23(23):8626-36.

24.

Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport.

Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, Stenoien DL, Young M, Faber PW, MacDonald ME, McPhaul MJ, Brady ST.

Neuron. 2003 Sep 25;40(1):41-52.

25.

Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.

Stenoien DL, Sen S, Mancini MA, Brinkley BR.

Cell Motil Cytoskeleton. 2003 Jun;55(2):134-46.

PMID:
12740874
26.

Molecular analysis of the androgen receptor in ten prostate cancer specimens obtained before and after androgen ablation.

Lamb DJ, Puxeddu E, Malik N, Stenoien DL, Nigam R, Saleh GY, Mancini M, Weigel NL, Marcelli M.

J Androl. 2003 Mar-Apr;24(2):215-25.

27.

Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus.

Dong S, Qiu J, Stenoien DL, Brinkley WR, Mancini MA, Tweardy DJ.

Oncogene. 2003 Feb 13;22(6):858-68.

PMID:
12584566
28.

Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.

Stenoien DL, Mielke M, Mancini MA.

Nat Cell Biol. 2002 Oct;4(10):806-10.

PMID:
12360291
29.

Alteration of large-scale chromatin structure by estrogen receptor.

Nye AC, Rajendran RR, Stenoien DL, Mancini MA, Katzenellenbogen BS, Belmont AS.

Mol Cell Biol. 2002 May;22(10):3437-49.

30.

Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor alpha-coactivator complexes in living cells.

Stenoien DL, Nye AC, Mancini MG, Patel K, Dutertre M, O'Malley BW, Smith CL, Belmont AS, Mancini MA.

Mol Cell Biol. 2001 Jul;21(13):4404-12.

31.

Subnuclear dynamics and transcription factor function.

Stenoien DL, Simeoni S, Sharp ZD, Mancini MA.

J Cell Biochem Suppl. 2000;Suppl 35:99-106. Review.

PMID:
11389538
32.

FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent.

Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA.

Nat Cell Biol. 2001 Jan;3(1):15-23.

PMID:
11146621
33.

Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1.

Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA.

Mol Endocrinol. 2000 Apr;14(4):518-34.

PMID:
10770489
34.

A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)

Nazareth LV, Stenoien DL, Bingman WE 3rd, James AJ, Wu C, Zhang Y, Edwards DP, Mancini M, Marcelli M, Lamb DJ, Weigel NL.

Mol Endocrinol. 1999 Dec;13(12):2065-75. Erratum in: Mol Endocrinol 2000 Apr;14(4):544.

PMID:
10598582
35.

Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract.

Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A.

Hum Mol Genet. 2000 Jan 1;9(1):133-44.

36.

Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.

Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA.

Hum Mol Genet. 1999 May;8(5):731-41.

PMID:
10196362
37.

Immunochemical analysis of kinesin light chain function.

Stenoien DL, Brady ST.

Mol Biol Cell. 1997 Apr;8(4):675-89.

38.

Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells.

Pfister KK, Wagner MC, Stenoien DL, Brady ST, Bloom GS.

J Cell Biol. 1989 Apr;108(4):1453-63.

Supplemental Content

Loading ...
Support Center